Overview

Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement

Status:
Unknown status
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
Chronic kidney disease (CKD) and (subsequent) acute kidney injury are frequent in patients undergoing transcatheter aortic valve implantation (TAVI). Moreover, these patients are easily hypervolemic and susceptible for cardiac decompensation. Prevention of contrast induced nephropathy (CIN) has not yet been studied in these patients, and evidence on different strategies is urgently needed. The objective of this study is to evaluate the efficacy of 250ml 1.4% sodium bicarbonate versus hypotone saline (0.65% sodiumchloride) hydration prior to TAVI in patients with CKD to prevent CIN.
Phase:
Phase 4
Details
Lead Sponsor:
St. Antonius Hospital